Try our beta test site
13343 studies found for:    Encephalopathy
Show Display Options
Rank Status Study
1 Not yet recruiting Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
Condition: Covert Hepatic Encephalopathy
Intervention: Drug: Rifaximin
2 Completed Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: L-ornithine L-aspartate;   Drug: Rifaximin;   Drug: Placebo
3 Completed Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Albumin;   Drug: Sodium chloride 0.9%
4 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
5 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
6 Recruiting A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China
Condition: Encephalopathy
Intervention:
7 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
8 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
9 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
10 Recruiting Metformin Experience on Minimal Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Metformin;   Drug: Placebo
11 Terminated The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
12 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
13 Completed Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Dietary Supplement: Branched-chain amino acids;   Dietary Supplement: Maltodextrin
14 Completed Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia
Condition: Hypoxic Ischemic Encephalopathy
Intervention: Drug: Topiramate in newborns with hypoxic ischemic encephalopathy treated with therapeutic hypothermia
15 Recruiting Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Conditions: Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention: Other: Autologous umbilical cord blood cells
16 Completed Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate;   Drug: Lactose
17 Recruiting Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
Condition: Hypoxic Ischaemic Encephalopathy
Intervention: Other: risk factors
18 Recruiting Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
Condition: Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)
Intervention: Biological: Autologous cord blood cell therapy
19 Completed Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
Conditions: Hepatic Cirrhosis;   Minimal Hepatic Encephalopathy
Interventions: Other: Auxiliary Treatment;   Dietary Supplement: Hyperproteic and fiber-rich diet;   Drug: Nitazoxanide
20 Completed Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.